Bumper Offer - Urjas oil Just @ Rs. 1
Dynapar EC 25 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Secondary and off-label uses of Dynapar EC 25 Tablet have also been mentioned below.
The correct dosage of Dynapar EC 25 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Dynapar EC 25 Tablet side effects, there are can be others also. These have been listed below. These side effects of Dynapar EC 25 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Dynapar EC 25 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Dynapar EC 25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Dynapar EC 25 Tablet related warnings section.
Individuals suffering from medical conditions like Stomach Infection, Skin Rash, Stroke must refrain from the use of Dynapar EC 25 Tablet since this can cause severe adverse effects. The section on Dynapar EC 25 Tablet contraindications lists all such conditions.
Besides this, Dynapar EC 25 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Dynapar EC 25 Tablet is safe while driving, and is is addictive in nature.
Dynapar EC 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Dynapar EC 25 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Dynapar. If you are pregnant, do not take Dynapar without a doctor's advice.
Is the use of Dynapar EC 25 Tablet safe during breastfeeding?
Side effects of Dynapar on breastfeeding women are very mild.
What is the effect of Dynapar EC 25 Tablet on the Kidneys?
Use of Dynapar may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Dynapar EC 25 Tablet on the Liver?
Dynapar may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Dynapar EC 25 Tablet on the Heart?
Dynapar can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Dynapar EC 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dynapar EC 25 Tablet unless your doctor advises you to do so -
Is this Dynapar EC 25 Tablet habit forming or addictive?
Dynapar EC 25 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Dynapar EC 25 Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Dynapar EC 25 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Dynapar EC 25 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Dynapar EC 25 Tablet
There is no information on the effects of taking Dynapar EC 25 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Dynapar EC 25 Tablet
Consumption of alcohol and Dynapar EC 25 Tablet together may have severe effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
